Deferiprone Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Deferiprone Market Size In 2021 is estimated to clock a modest CAGR of 1% during the forecast Period 2021-2027.

Deperipron is an iron chelator indicated for the treatment of patients with transfusion iron overload due to thalassemia syndrome, primarily where current chelation therapies are insufficient. Chelation therapy is used to remove the build-up of toxic metals such as lead, iron, mercury, and arsenic. It prevents the patient from experiencing severe thalassemia symptoms. An FDA-approved drug, deferiprone is primarily used to treat transfusion-dependent thalassemia and other related disorders. Deferiprone is a low molecular weight bidentate hydroxypyridone (139). It forms a stable complex with iron and is then excreted in the urine. It is metabolized by glucuronidation in the liver and has a relatively short half-life of 47-134 minutes, requiring multiple daily administration.


Market Segments

By Formulation:

  • Tablet
  • Oral Solution
  • Capsule

By Indication:

  • Transfusional Iron Overload
  • NTDT Caused Iron Overload

Key Players

Some of the major companies such as Cipla Limited., Apotex Inc., Swedish Orphan Biovitrum AB (publ)., Genepharm S.A., Lipomed AG., Drug International Limited., Ambrosia Remedies (P) Ltd., and Focus Pharmaceuticals Limited.


Scope of the Report

The research study analyzes the global Deferiprone industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Deferiprone Market Report

1. What was the Deferiprone Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Deferiprone Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Deferiprone Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation